Research Paper | Published:

Development and Application of Bacillus Thuringiensis Var. Israelensis Serotype H 14 as an Effective Biological Control Agent Against Mosquitoes in Israel



The use of a new strain of Bacillus thuringiensis has been successfully used in mosquito control in Israel. Toxicity tests with Culex pipiens and Aedes aegypti showed that the strain was effective in LD50 bioassays. Field trials with B. thuringiensis showed that several applications were needed and the organism shows promise to replace currently used insecticides.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Saliternik, Z., 1964. Malaria and its control in Israel. Hacohen Press. Jerusalem, 183 pp.

  2. 2

    Goldberg, L. and Margalit, J., 1977. Bacterial spore demonstrating rapid larvicidae activity against Anopheles sergentii, Uronutaenia unguiculata, Culex univittatus, Aedes aegypti, and Culex pipiens . Mosquito News 37: 355–358.

  3. 3

    de Barjac, H., 1978. Une nouvelle variete de Bacillus thuringiensis tres toxique pour le moustique: B. thuringiensis var. israelensis serotype 14. C.R. Acad. Sci. (Paris), 2860: 797–800.

  4. 4

    WHO VBC Document, 1982. Data sheet on the biological control agent: Bacillus thuringiensis var. israelensis Serotype H14 (de Barjac, 1978). WHO mimeographed document WHO/VBC/79. 750 Rev. 1.

Download references

Author information

Rights and permissions

To obtain permission to re-use content from this article visit RightsLink.

About this article